Issue 23, 2025

Vanadium ferrite-doped mesoporous bioactive glass-ceramics: controlled cisplatin delivery in chemohyperthermia

Abstract

This study explores the multifunctional application of vanadium ferrite-doped mesoporous bioactive glass-ceramics (MBGCs), presenting a novel approach to synergistically integrate chemohyperthermia and controlled cisplatin delivery in cancer treatment. Using the sol–gel method, MBGC formulations were developed, which VF0510 (a formulation containing 5 mol% V2O5 and 10 mol% Fe2O3) identified as the optimal composition due to its superior magnetic properties, bioactivity, and controlled drug delivery capabilities. The previously established mesoporous architecture of VF0510, validated in our earlier study, enabled effective cisplatin loading and sustained release in this work. Calorimetric analyses revealed that VF0510 achieved a controlled therapeutic temperature of 41.5 °C under an alternating magnetic field, meeting the optimal range for hyperthermia-based treatments. Drug loading studies demonstrated that hydroxypropyl cellulose (HPC)-coated VF0510 provided a sustained release of 68% over 48 hours, significantly reducing the burst effect while maintaining prolonged therapeutic action. In vitro assays using MG63 osteosarcoma cells demonstrated statistically significant results (P < 0.01), with cisplatin-loaded VF0510 reducing cell viability by 45% within 48 hours through apoptosis induction, as confirmed by flow cytometry. This dual-modality platform integrates localized magnetic hyperthermia with controlled chemotherapy delivery, addressing challenges such as systemic toxicity and drug resistance. The results highlight the critical role of vanadium ferrite in enhancing magnetic response and bioactivity, while the HPC coating ensures sustained and efficient drug release. Future research should optimize the thermoresponsive properties of polymer coatings and validate findings through in vivo models, paving the way for safer, more effective cancer therapies combining hyperthermia and chemotherapy.

Graphical abstract: Vanadium ferrite-doped mesoporous bioactive glass-ceramics: controlled cisplatin delivery in chemohyperthermia

Article information

Article type
Paper
Submitted
21 Mar 2025
Accepted
27 May 2025
First published
03 Jun 2025
This article is Open Access
Creative Commons BY-NC license

RSC Adv., 2025,15, 18657-18669

Vanadium ferrite-doped mesoporous bioactive glass-ceramics: controlled cisplatin delivery in chemohyperthermia

S. Omidian, M. H. Nazarpak, Z. Bagher and F. Moztarzadeh, RSC Adv., 2025, 15, 18657 DOI: 10.1039/D5RA01999K

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements